Vesting condition for the incentive have been met. A well deserved reward for the Neuren employees if you ask me
from the annoucment dated 03/02/2022
Material terms:- Exercise price ($3.46 per share) is the volume weighted average price (VWAP) at which the Company's shares weretraded on the ASX in the 5 days preceding the date of issue of the Options.
- Vested options may be exercised no earlier than 1 year after the issue date.
- All options lapse 4 years after the issue date.
- Options are subject to the following vesting conditions:
(a) when the Company determines to progress NNZ-2591 to a Phase 2b or Phase 3 clinical trial following a positive Phase2 clinical trial outcome, or executes a partnering transaction for NNZ-2591;
(b) when the Company executes a partnering transaction for trofinetide outside North America, or submits a MarketingAuthorisation Application for trofinetide in the European Union, the United Kingdom or Japan.
(c) on acceptance by the US FDA of the filing of a New Drug Application for trofinetide.- The options carry no entitlement to vote or participate in new issues.
- Forums
- ASX - By Stock
- Ann: Application for quotation of securities - NEU
Vesting condition for the incentive have been met. A well...
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B |
Open | High | Low | Value | Volume |
$19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 246 | $19.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.99 | 512 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 19.760 |
1 | 1200 | 19.720 |
1 | 540 | 19.710 |
1 | 50 | 19.700 |
1 | 300 | 19.680 |
Price($) | Vol. | No. |
---|---|---|
20.100 | 100 | 1 |
20.190 | 1000 | 1 |
20.410 | 280 | 1 |
20.500 | 2000 | 1 |
20.820 | 2286 | 2 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |